SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:1931687"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:1931687" > Long-term angiotens...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension

Ekholm, M (author)
Karolinska Institutet
Wallen, NH (author)
Karolinska Institutet
Johnsson, H (author)
show more...
Eliasson, K (author)
Kahan, T (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2002-07-04
2002
English.
In: Clinical science (London, England : 1979). - : Portland Press Ltd.. - 0143-5221 .- 1470-8736. ; 103:2, s. 151-155
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Antihypertensive treatment reduces the risk of thromboembolic events in hypertension. The aim of this study was to examine the influence of angiotensin-converting enzyme inhibition on blood coagulation in subjects with mild-to-moderate essential hypertension. Fibrinogen, thrombin–antithrombin complex (TAT) and Factor VII were determined in plasma at rest and after a mental stress test following placebo for 6 weeks, or ramipril for 6 weeks or 6 months. Ramipril reduced resting TAT, and tended to reduce fibrinogen; Factor VII remained unchanged. Mental stress increased fibrinogen, but did not alter TAT or Factor VII activity. The reduced thrombin generation in patients taking ramipril may explain in part why angiotensin-converting enzyme inhibitors reduce thromboembolic complications in patients with cardiovascular disease.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Ekholm, M
Wallen, NH
Johnsson, H
Eliasson, K
Kahan, T
Articles in the publication
Clinical science ...
By the university
Karolinska Institutet

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view